Danielle Stockhorst
Family · Pleasanton, TXNPI 1154727790
Payments from drug & device makers
Across 189 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$593
- AstraZeneca$558
- AbbVie$531
- Amgen$269
- Novo Nordisk$247
- Currax Pharmaceuticals LLC$181
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,42397%
- Education$1103%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 32 | $593 |
| AstraZeneca | 26 | $558 |
| AbbVie | 33 | $531 |
| Amgen | 14 | $269 |
| Novo Nordisk | 14 | $247 |
| Currax Pharmaceuticals LLC | 13 | $181 |
| Pfizer | 8 | $161 |
| Astellas Pharma US Inc | 4 | $145 |
| Abbott | 5 | $109 |
| Shield Therapeutics Inc | 6 | $105 |
| Exact Sciences | 4 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $80 |
| Merck | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Dexcom, Inc. | 2 | $49 |
| Bayer | 2 | $44 |
| Boehringer Ingelheim | 2 | $41 |
| Tolmar, Inc. | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Corium, LLC | 1 | $25 |
| Antares Pharma, Inc. | 1 | $21 |
| GSK | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $13 |
How this compares
$3,533 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 73 | $81,349 |
| OzempicSemaglutide | 35 | $38,919 |
| JardianceEmpagliflozin | 38 | $35,524 |
| FarxigaDapagliflozin Propanediol | 22 | $22,292 |
| TrulicityDulaglutide | 18 | $21,147 |
| EliquisApixaban | 27 | $18,030 |
| XareltoRivaroxaban | 14 | $14,089 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $13,072 |
| MyrbetriqMirabegron | 18 | $12,534 |
| Xigduo XrDapaglifloz Propaned/Metformin | 16 | $10,567 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $9,968 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 35 | $6,470 |
| JanuviaSitagliptin Phosphate | 11 | $6,109 |
| PremarinEstrogens, Conjugated | 13 | $5,694 |
| Gabapentin | 159 | $3,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $593 | $102,49691 claims |
| Novo NordiskOzempic | $247 | $38,91935 claims |
| Boehringer IngelheimJardiance | $41 | $35,52438 claims |
| PfizerEliquis, Premarin | $161 | $23,72340 claims |
| AstraZenecaFarxiga | $558 | $22,29222 claims |
| MerckJanumet Xr, Januvia | $77 | $16,07723 claims |
| Astellas Pharma US IncMyrbetriq | $145 | $12,53418 claims |
| AbbVieLexapro, Synthroid | $531 | $5,80349 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.
Other family in Pleasanton
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.